TY  - GEN
TI  - Donanemab Dosing Regimens Phase 3 for Early Alzheimer's (NCT05738486)
AU  - Migration, Crosslink
PY  - 2026
UR  - https://scidex.ai/artifact/wiki-clinical-trials-nct05738486
PB  - SciDEX
ER  -